Reinaldo “Rey” Pascual

Rey Pascual is an accomplished financial professional with years of experience in investment banking, private equity and venture capital. Over the course of his career, Rey has advised large corporations, executed investments, and partnered with management teams to help support their strategic priorities through financial analysis and insights. As Chief Financial Officer of U.S. Urology Partners, Rey leads the company’s financial organization and oversees its capital deployment strategy, both organically and via mergers and acquisitions.

Prior to joining U.S. Urology Partners, Rey was a healthcare investor at General Catalyst, where he supported late-stage growth investments including Sword Health, Dandy, Harbor Health and Transcarent. He played a key role in Transcarent’s take-private acquisition of Accolade (Nasdaq: ACCD). Prior to General Catalyst, Rey was a member of the healthcare team at General Atlantic, where he led investment efforts and advised portfolio companies on financial strategy and M&A execution. His work included partnerships with Gravie, Marathon Health and ACES, among others.  Rey began his career in investment banking at Centerview Partners, advising Fortune 500 companies across the managed care, industrials and consumer sectors.

Rey holds a B.A. in Economics from Harvard College, where he graduated in three years and was a member of the varsity baseball team.